96. Crohn disease
2,209 clinical trials,   1,276 drugs   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways

Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01291810
(ClinicalTrials.gov)
February 201117/12/2010Clinical Efficacy of TNFa Kinoid in Crohn's Disease PatientsA Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy, Safety and Immunogenicity of Neovacs' TNFa-Kinoid in Adult Subjects With Crohn's DiseaseCrohn's DiseaseBiological: TNF Kinoid;Biological: WFINeovacsNULLCompleted18 Years65 YearsBoth66Phase 2Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Hungary;Netherlands;Romania
2NCT00808262
(ClinicalTrials.gov)
October 200812/12/2008Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's DiseaseA Phase I/II, Open-label, Escalating Dose, Optimal Two-stage, Study of TNFa-Kinoid (TNF- K) Immunization in Crohn's Disease PatientsCrohn's DiseaseBiological: TNFa KinoidNeovacsNULLCompleted18 Years65 YearsBoth21Phase 1;Phase 2South Africa;Switzerland